CD4+ T-cell induction of Fas-mediated apoptosis in Burkitt's lymphoma B cells

Blood

Volumn 88, Issue 4, 1996, Pages 1375-1382

  Schattner, Elaine J ^a   Mascarenhas, John ^b   Bishop, Julie ^b   Yoo, Dae Hyun ^b   Chadburn, Amy ^b   Crow, Mary K ^b   Friedman, Steven M ^b  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD40 ANTIGEN; FAS ANTIGEN;

APOPTOSIS; ARTICLE; B LYMPHOCYTE; BURKITT LYMPHOMA; CELL MEDIATED CYTOTOXICITY; CONTROLLED STUDY; EPSTEIN BARR VIRUS; HELPER CELL; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; PRIORITY JOURNAL;

EID: 0029797008     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.4.1375.bloodjournal8841375     Document Type: Article

References (38)

1. Trauth BC, Klas C, Peters AMJ, Matzku S, Moller P, Falk W, Debatin K-M, Krammer PH: Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245:301, 1989
2. Oehm A, Behrmann I, Falk M, Pawlita M, Maier G, Klas C, Li-Weber M, Richards S, Dhein J, Trauth BC, Ponsting H, Krammer PH: Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. J Biol Chem 267:10709, 1992
3. Suda T, Takahashi T, Golstein P, Nagata S: Molecular cloning and expression of the Fas ligand: A novel memer of the tumor necrosis factor family. Cell 75:1169, 1993
4. + cytotoxic T cells. Proc Natl Acad Sci USA 91:4185, 1994
5. Alderson MR, Tough TW, Davis-Smith T, Braddy S, Falk B, Schooley KA, Goodwin RG, Smith CA, Ramsdell F, Lynch DH: Fas ligand mediates activation-induced cell death in human T lymphocytes. J Exp Med 181:71, 1995
6. + T cells. Nature 376:181, 1995
7. Falk MH, Trauth BC, Debatin K-M, Klas C, Gregory CD, Rickinson AB, Calender A, Lenoir GM, Ellwart JW, Krammer PH, Bornkamm GW: Expression of the APO-1 antigen in Burkitt lymphoma cell lines correlates with a shift towards a lymphoblastoid phenotype. Blood 79:3300, 1992
8. Shima Y, Nishimoto N, Ogata A, Fujii Y, Yoshizaki K, Kishimoto T: Myeloma cells express Fas antigen/APO-1 (CD95) but only some are sensitive to anti-Fas antibody resulting in apoptosis. Blood 85:757, 1995
9. Sato T, Irie S, Kitada S, Reed JC: FAP-1: A protein tyrosine phosphatase that associates with Fas. Science 268:411, 1995
10. Murray RJ, Kurilla MG, Brooks JM, Thomas WA, Rowe M, Kieff E, Rickinson AB: Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): Implications for the immune control of EBV-positive malignancies. J Exp Med 176:157, 1992
11. Papadopoulos EB, Ladanyi M, Emanuel D, Mackinnon S, Boulad F, Carabasi MH, Castro-Malaspina H, Childs BH, Gillio Ap, Small TN, Young JW, Kernan NA, O'Reilly RJ: Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation. N Engl J Med 330:1185, 1994
12. Silver BA, Bostick-Bruton FW, Neckers L, Fisher RI: Deficient helper cell function as a cause of diminished pokeweed mitogen blastogenic responses in patients with non-Hodgkin's lymphomas. Cancer 54:2936, 1984
13. Lauritzsen GF, Weiss S, Dembic Z, Bogen B: Naive idiotype-specific CD4+ T cells and immunosurveillance of B-cell tumors. Proc Natl Acad Sci USA 91:5700, 1994
14. Kwak LW, Taub DD, Duffey PL, Bensinger WI, Bryant EM, Reynolds CW, Longo DL: Transfer of myeloma idiotype-specific immunity from an actively immunised marrow donor. Lancet 345:1016, 1995
15. Rothstein TL, Wang JK, Panka DJ, Foote LC, Wang Z, Stanger B, Cui H, Ju S-T, Marshak-Rothstein A: Protection against Fas-dependent Th I-mediated apoptosis by antigen receptor engagement in B cells. Nature 374:163, 1995
16. Gregory CD, Tursz T, Edwards CF, Tetaud C, Talbot M, Caillou B, Rickinson AB, Lipinski M: Identification of a subset of normal B cells with a Burkitt's lymphoma (BL)-like phenotype. J Immunol 139:313, 1987
17. Klein G: Epstein-Barr virus strategy in normal and neoplastic B cells. Cell 77:791, 1994
18. Schattner E, Elkon KB, Yoo D-H, Tumang J, Krammer PH, Crow MK, Friedman SM: CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway. J Exp Med 182:1557, 1995
19. Garrone P, Neidhardt E-M, Garcia E, Galibert L, van Kooten C, Banchereau J: Fas ligation induces apoptosis of CD40-activated human B lymphocytes. J Exp Med 182:1265, 1995
20. + T cells that induces contact-dependent B cell differentiation (help). J Exp Med 175:1091, 1992
21. Roussel F, Garcia E, Banchereau J: Cytokine-induced proliferation and immunoglobulin production of human B lymphocyes triggered through their CD40 antigen. J Exp Med 173:705, 1991
22. Paris M, Gaskin F, Parsons JT, Fu SM: CD40 signaling pathway: Anti-CD40 monoclonal antibody induces rapid dephosphorylation and phosphorylation of tyrosine-phosphorylated proteins including protein tyrosine kinase lyn, fyn, and syk and the appearance of a 28-kD tyrosine phosphorylated protein. J Exp Med 179:1923, 1994
23. Liu Y-J, Joshua DE, Williams GT, Smith CA, Gordon J, MacLennan FCM: Mechanism of antigen-driven selection in germinal centers. Nature 342:929, 1989
24. Lenoir GM, Vuillaume M, Bonnardel C: The use of lymphomatous and lymphoblastoid cell lines in the study of Burkitt's lymphoma, in Lenoir GM, O'Conor GT, Olweny CLM (eds): Burkitt's Lymphoma: A Human Cancer Model. Lyon, France, International Agency for Research on Cancer, 1985 p 309
25. + T cell leukemia subclone with contact-dependent helper function. J Immunol 147:3389, 1991
26. 3-thymidine incorporation assay. J Immunol Methods 170:211, 1994
27. Owen-Schaub LB, Yonehara S, Crump WL III, Grimm EA: DNA fragmentation and cell death are selectively triggered by activated human lymphocytes by Fas antigen engagement. Cell Immunol 140:197, 1992
28. Levine A: Acquired immunodeficiency syndrome-related lymphoma. Blood 80:8, 1992
29. Onel KB, Tucek-Szabo CL, Ashany D, Lacy E, Nikolic-Zugic J, Elkon KB: Expression and function of the murine CD95/FasR/ APO-1 receptor in relation to B cell ontogeny. Eur J Immunol 25:2940, 1995
30. Mosialos G, Birkenbach M, Yalamanchili R, VanArsdale T, Ware C. Kieff E: The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell 80:389, 1995
31. Cheng G, Cleary AM, Ye SZ, Hong DI, Lederman S, Baltimore D: Involvement of CRAF1, a relative of TRAF, in CD40 signaling. Science 267:1494, 1995
32. Jain R, Roncella S, Hashimoto S, Carbone A, Francia di Celle P, Roa R, Ferrarini M, Chiorazzi N: A potential role for antigen selection in the clonal evolution of Burkitt's lymphoma. J Immunol 153:45, 1994
33. Ziegler JL, Beckstead JA, Volberding PA, Abrams DI, Levine AM, Lukes RJ, Gill PS, Burkes RL, Meyer PR, Metroka CE, Mouradian J, Moore A, Riggs SA, Butler JJ, Cabanillas FC, Hersh E, Newell GR, Laubenstein LJ, Knowles D, Odajnyk C, Raphael B, Koziner B, Urmacher C, Clarkson BD: Non-Hodgkin's lymphoma in 90 homosexual men. N Engl J Med 311:565, 1984
34. Knowles DM, Chamulak G, Subar M, Pelicci PG, Dugan M, Burke JS, Raphael B, Dalla-Favera R: Clinicopathologic, immunophenotypic and molecular genetic analysis of AIDS-associated lymphoid neoplasia. Pathol Ann 23:33, 1988
35. Shiramizu B, Herndier B, Meeker T, Kaplan L, McGrath M: Molecular and immunophenotypic characterization of AIDS-associated, Epstein-Barr virus-negative, polyclonal lymphoma. J Clin Oncol 10:383, 1992
36. Cohen AJ, Philips TM, Kessler CM: Circulating coagulation ihibitors in the acquired immunodeficiency syndrome. Ann Intern Med 104:175, 1986
37. MillerLH, Good MF, Milon G: Malaria pathogenesis. Science 264:1878, 1994
38. Moller P, Henne C, Leithauser F, Eichelmann A, Schmidt A, Brudertein S, Dhein J, Krammer P: Coregulation of the APO-1 antigen with intercellular adhesion molecule-1 (CD54) in tonsillar B cells and coordinate expression in follicular center B cells and in follicular center and mediastinal B cell lymphomas. Blood 81:2067, 1993